Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

Box plots of the three-dimensional displacement variations and the COR. حسب Yifei Li (198040)

Composition of total phenols in milligram gallic acid equivalents per gram (mg GAE/g), flavonoid and tannin as catechin equivalents (mg CTE/g), saponin (g/Kg) and alkaloids (%) in... حسب Kebede Gelgelo (20329794)

الموضوعات:

Correlation between season, altitude and the secondary metabolite examined in <i>Commelina</i> species. حسب Kebede Gelgelo (20329794)

الموضوعات:

ANOVA table for effect of season, species, altitude and their interaction on secondary metabolite composition of <i>Commelina</i> species. حسب Kebede Gelgelo (20329794)

الموضوعات:

Composition of total phenols in milligram gallic acid equivalents per gram (mg GAE/g), flavonoid and tannin as catechin equivalents (mg CTE/g), saponin (g/Kg) and alkaloids (%) in... حسب Kebede Gelgelo (20329794)

الموضوعات:

Seasonal variability in the secondary metabolite content of <i>Commelina</i> species. حسب Kebede Gelgelo (20329794)

الموضوعات:

Altitudinal variability in the secondary metabolite content of <i>Commelina</i> species. حسب Kebede Gelgelo (20329794)

الموضوعات:

Composition of total phenols in milligram gallic acid equivalents per gram (mg GAE/g), flavonoid and tannin as catechin equivalents (mg CTE/g), saponin (g/Kg) and alkaloids (%) in... حسب Kebede Gelgelo (20329794)

الموضوعات:

Composition of total phenols in milligram gallic acid equivalents per gram (mg GAE/g), flavonoid and tannin as catechin equivalents (mg CTE/g), saponin (g/Kg) and alkaloids (%) in... حسب Kebede Gelgelo (20329794)

الموضوعات:

Table 1_The impact of IL-17A inhibitors on scalp and gut microbiota in psoriasis.docx حسب Wenxia Huang (12290795)

"…Moreover, the abundance of Roseburia, Megamonas, and the phylum Bacteroidota increased, although the Firmicutes/Bacteroidota (F/B) ratio showed no significant change. Conclusion: IL-17A inhibitor therapy has the potential to improve the structure and diversity of the scalp microbiome, gradually restoring it toward a healthier state while also enhancing gut microbiota diversity. …"

Data Sheet 1_Unveiling frailty: comprehensive and sex-specific characterization in prematurely aging PolgA mice.pdf حسب Dilara Yılmaz (19710658)

"…We demonstrated that frailty became evident in PolgA mice around 40 weeks, validated through body weight loss, reduced walking speed, decreased physical activity, and weaker grip strength. …"

Image 1_CHMP4A in hepatocellular carcinoma: exploring its role in tumor progression, immune modulation, and potential link to TIM3 checkpoint.pdf حسب Kai Sun (140584)

"…Background<p>Charged Multivesicular Body Protein 4A (CHMP4A), a member of the ESCRT-III family, plays a pivotal role in membrane remodeling and fission, with emerging evidence underscoring its significance in cancer immunotherapy. …"

Table 1_CHMP4A in hepatocellular carcinoma: exploring its role in tumor progression, immune modulation, and potential link to TIM3 checkpoint.docx حسب Kai Sun (140584)

"…Background<p>Charged Multivesicular Body Protein 4A (CHMP4A), a member of the ESCRT-III family, plays a pivotal role in membrane remodeling and fission, with emerging evidence underscoring its significance in cancer immunotherapy. …"

Table 2_CHMP4A in hepatocellular carcinoma: exploring its role in tumor progression, immune modulation, and potential link to TIM3 checkpoint.docx حسب Kai Sun (140584)

"…Background<p>Charged Multivesicular Body Protein 4A (CHMP4A), a member of the ESCRT-III family, plays a pivotal role in membrane remodeling and fission, with emerging evidence underscoring its significance in cancer immunotherapy. …"